ONCOLYTICS BIOTECH INC
ONCOLYTICS BIOTECH INC (ONCY): 5 pipeline candidates · 1 upcoming catalyst · ~3 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
2.5 months
D/E -2.59 · 0% dilution
Lead: Phase 2
5 candidates
1 upcoming, next in ~196d
14 buys · 0 sells (180d)
A transparent, data-derived signal for ONCOLYTICS BIOTECH INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$111.2M
Cash
$5.5M
Quarterly Burn
$7.3M
Runway
2.5 mo
Revenue
—
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| folfiri | Phase 2 |
| mfolfirinox treatment regimen | Phase 2 |
| not specified | — |
| pelareorep | Phase 2 |
| trifluridine tipiracil | Phase 1/Phase 2 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
2
Total value held
$731K
| Holder | Shares | Value |
|---|---|---|
| marshall wace, llp | 859,831 | $731K |
| sound income strategies, llc | 194 | $180 |
Frequently asked questions
How many drug candidates are in ONCOLYTICS BIOTECH INC's pipeline?
ONCOLYTICS BIOTECH INC (ONCY) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ONCOLYTICS BIOTECH INC's lead drug candidate?
ONCOLYTICS BIOTECH INC's most advanced tracked candidate is folfiri (Phase 2) for Ras-mutated Metastatic Colorectal Cancer.
What is ONCOLYTICS BIOTECH INC's next catalyst?
ONCOLYTICS BIOTECH INC's next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: pelareorep" — expected December 31, 2026.
What is ONCOLYTICS BIOTECH INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ONCOLYTICS BIOTECH INC has approximately 2.5 months of cash runway.
What is ONCOLYTICS BIOTECH INC's market capitalization?
ONCOLYTICS BIOTECH INC's market capitalization is approximately $111.2M.
Get the full picture on ONCOLYTICS BIOTECH INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.